Techne Buys Shanghai PrimeGene Bio-Tech

Techne will acquire Shanghai PrimeGene Bio-Tech, a company that makes recombinant proteins for research and diagnostic applications. Techne is a US company that offers research proteins in China through a subsidiary, R&D Systems China, which will be the purchaser. Techne said the purchase will add China manufacturing capacity and over 400 new protein products to its portfolio. More details.... Stock Symbol: (NSDQ: TECH) Share this with colleagues: // //